Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-28T09:42:41.441Z Has data issue: false hasContentIssue false
  • English
  • Français

Emporiatrics: Protecting Travelers From Malaria

Published online by Cambridge University Press:  21 June 2016

Mary D. Nettleman
Mary D. Nettleman*
Affiliation:
Department of Internal Medicine, Division of Clinical Epidemiology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa
*
Department of Internal Medicine, C41 GH, University of Iowa Hospitals and Clinics, Iowa City, IA 52242
Get access Rights & Permissions [Opens in a new window]

Extract

Although we think of malaria as a disease of the tropics, it is sobering to recall that in the beginning of this century, more than two-thirds of the earth's population lived in areas where malaria was endemic. The United States and Europe were both rife with malaria, and the disease changed the course of world history many times. Indeed, in Western Africa during 1942, the incidence of malaria was as high as 1,071 cases per 1,000 soldiers per year.

Type
Emporiatrics
Information
Infection Control & Hospital Epidemiology , Volume 11 , Issue 7 , July 1990 , pp. 380 - 383
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Manson's Tropical Diseases. 19th ed. Manson-Bahr, PEC, Bell, DR, eds. London: Balliere Tindall: 1987.Google Scholar
2. Bruce-Chwatt, LJ. Mosquitos, malaria and war; then and now. J R Army Med Corps. 1985;131:85–99.CrossRefGoogle ScholarPubMed
3. Wyler, DJ. The ascent and decline of chloroquine. JAMA. 1984;251:2420–2422.CrossRefGoogle ScholarPubMed
4. Herwaldt, BL, Krogstad, DJ, Slesinger, PH. Antimalarial agents: specific chemoprophylaxis regimens. Antimicroh Agents Chemother. 1988;23:953–956.CrossRefGoogle Scholar
5. Murphy, JR, Clyde, DF, Herrington, DA, et al. Continuation of chloro-quine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy. Antimicroh Agents Chemother. 1990;34:676–679.CrossRefGoogle ScholarPubMed
6. Guerrero, IC, Weniger, BG, Schultz, MG. Transfusion malaria in the United States, 1972-1981. Ann Intern Med. 1983;99:221–226.CrossRefGoogle ScholarPubMed
7. Malviva, S, Shurin, SB. Congenital malaria: case report and review. Clin Pediatr (Phila). 1984;23:516–517.CrossRefGoogle Scholar
8. Centers for Disease Control. Recommendations for the prevention of malaria among travelers. MMWR. 1990;39:1–10.Google Scholar
9. Health Information for International Travel, 1989. Atlanta, Ga: Centers for Disease Control; 1989. U.S. Dept. of Health and Human Services publication CDC 89-8280.Google Scholar
10. Cook, GC. Prevention and treatment of malaria. Lancet. 1988;1:32–37.CrossRefGoogle ScholarPubMed
11. Centers for Disease Control. Seizures temporally associated with use of DEET insect repellent-New York and Connecticut. MMWR. 1989;39:678–680.Google Scholar
12. Cook, IF. Malarial prophylaxis with chloroquine/proguanil. Med J Austr. 1987;146:120.CrossRefGoogle ScholarPubMed
13. Insect repellants. Med Lett Drugs Ther, 1989;31:45–47.Google Scholar
14. Nevill, CG, Watkms, WM, Carter, JY, Munafu, CG. Comparison of mosquito nets, proguanil hydrochloride, and placebo to prevent malaria. Br Med J. 1988;297:401–404.CrossRefGoogle ScholarPubMed
15. Peto, TEA, Gilks, CF. Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet. 1986;1:1256–1260.CrossRefGoogle ScholarPubMed
16. Riou, B, Barriot, P, Rimailho, A, Baud, F. Treatment of severe chloroquine poisoning. N Engl J Med. 1988;318:1–6.CrossRefGoogle ScholarPubMed
17. Centers for Disease Control. Childhood chloroquine poisonings-Wisconsin and Washington. MMWR. 1988;37:437–439.Google Scholar
18. Patchen, LC, Campbell, CC, Williams, SB. Neurologic reactions after a therapeutic dose of mefloquine. N Engl J Med. 1989;321:1415.Google ScholarPubMed
19. Bjorkman, A. Acute psychosis following mefloquine prophylaxis. Lancet. 1989;2:865.CrossRefGoogle ScholarPubMed
20. Rouveix, B. Bricaire, F, Michon, C, Fanssen, G, Lebras, J. Mefloqyine and an acute brain syndrome. Ann Intern Med. 1989;110:577–578.CrossRefGoogle Scholar
21. Food and Drug Administration. Mefloquine approved for malaria. FDA Drug Bulletin. July 1989;17.Google Scholar
22. Karwacki, JJ, Webster, HK, Limsomwong, N, Shanks, GD. Two cases of mefloquine resistant malaria in Thailand. Trans R Soc Trop Med Hyg. 1989;83:152–153.CrossRefGoogle ScholarPubMed
23. WHO Update. Development of mefloquine as an antimalarial drug. Bull WHO. 1983;61:169–178.Google Scholar
24. Currie, B, Biddulph, J, Wesche, D, Pyakalyia, T. Malaria prophylaxis. Med J Austr. 1989;150:166.10.5694/j.1326-5377.1989.tb136407.xCrossRefGoogle Scholar
25. Baily, GG. Misuse of mefloquine for malaria prophylaxis in Zimbabwe. Lancet. 1987;1:53.CrossRefGoogle ScholarPubMed
26. Centers for Disease Control. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum . JAMA. 1985;253:2483–2486.CrossRefGoogle Scholar
27. Centers for Disease Control. Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine-sulfadoxine. MMWR. 1989;38:363–367.Google Scholar
28. Miller, KD, Lobel, HO, Satriale, RF, Kuntsky, JN, Stern, R, Campbell, CC. Severe cutaneous reactions among American travelers using pyn-methamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg. 1986;35:451–458.CrossRefGoogle ScholarPubMed
29. Dardick, KR. The availability of proguanil for overseas travelers. JAMA. 1989;261:247.Google ScholarPubMed
30. Limsomwong, N, Bang, LW, Singharaj, B. Malaria prophylaxis with 24. Health Hints for the Tropics. Wolfe, M, ed. Washington, DC: American Society for Tropical Medicine and Hygiene; 1989.Google Scholar
31. Coosemans, MH, Barutwanayo, M, Onori, E, Otoul, C, Gryseels, B, Wery, M. Double-blind study to assess the efficacy of chlorproguanil given alone or in combination with chloroquine for malaria chemoprophylaxis in an area with Plasmodium falciparum resistance to chloroquine, pyrimethamine, and cycloguanil. Trans R Soc Trop Med Hyg. 1987;81:151–156.CrossRefGoogle ScholarPubMed
32. Henderson, A, Simon, JW, Melia, W. Failure of malaria chemoprophylaxis with a proguanil-chloroquine combination in Papua New Guinea. Trans R Soc Trop Med Hyg. 1986;80:838–840.CrossRefGoogle ScholarPubMed